Ann: Bionomics and Merck Collaboration Presentation, page-4

I like this: "Under the agreement, Merck will fund all research and development, including clinical
development, and will be responsible for worldwide commercialisation of any products from the
collaboration. Bionomics will receive upfront payments totalling US$20 million and is eligible to
receive up to US$506 million for achievement of certain research and clinical development
milestones and undisclosed royalties on any product sales."